Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of Neurology and director of the UAB Huntington’s Disease Clinic, reacted to the ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

With informed consent, you generally have the right to seek a second opinion or refuse treatment unless refusing poses a danger to the community or a court of law declares you “mentally incompetent.” ...

Let’s be real: When it comes to detecting heart disease risk, you probably aren’t checking your skin first. And why would you? Skin health and heart health are unrelated, right? Not quite, doctors say ...

- Zodasiran targets ANGPLT3, an emerging therapeutic target to treat HoFH and other dyslipidemias - YOSEMITE Phase 3 study further enhances Arrowhead’s late-stage pipeline of RNAi-based ...

Department of Gastroenterology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China. The incidence of gastric xanthelasma exhibits regional variations and can occur across all age ...

ROANOKE, Va. (WDBJ) - A growing number of people in Central Virginia are being diagnosed with Alpha-Gal Syndrome. It’s an allergy caused by tick bites that makes eating—or even being near—meat or ...

Shawn Connolly, a former skateboarding professional, follows the directions of Nicholas B. Galifianakis, MD, while testing a deep brain stimulation treatment for Parkinson’s disease. Photo by Maurice ...

The FDA on Friday approved chenodiol (Ctexli) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Chenodiol -- a naturally occurring human bile acid also known as chenodeoxycholic ...

Familial hypercholesterolemia (FH) is a genetic disease, usually with onset during childhood, characterized by elevated blood LDL cholesterol levels and potentially associated with severe ...